Akamine Scott

Track

Insider profile

Performance

Overall performance
1.1
Performance over holding periods
1.1
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Akamine Scott's trades of Cerevel Therapeutics Holdings Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-12-21 2023-12-20
S Sale
82,971 -23.3%
195.42
US$3,309,114 		82,971 -23.3% 195.42 US$3,309,114
2023-12-07 2023-12-07
PrS Proposed sale
18,300
55.20
US$596,430 		18,300 55.20 US$596,430
2023-12-07 2023-12-07
PlS Planned sale
62,470 -35.6%
235.46
US$4,247,277 		62,470 -35.6% 235.46 US$4,247,277
2023-12-07 2023-12-05
PlS Planned sale
7,500 -93.6%
35.00
US$262,500 		7,500 -93.6% 35.00 US$262,500
2023-12-05 2023-12-05
PrS Proposed sale
7,500
35.00
US$262,500 		7,500 35.00 US$262,500
2022-08-09 2022-08-08
PlS Planned sale
10,000 -100.0%
40.00
US$400,001 		10,000 -100.0% 40.00 US$400,001